AR048106A1 - Dispositivo de distribucion de drogas visible por rayos x - Google Patents

Dispositivo de distribucion de drogas visible por rayos x

Info

Publication number
AR048106A1
AR048106A1 ARP050101064A ARP050101064A AR048106A1 AR 048106 A1 AR048106 A1 AR 048106A1 AR P050101064 A ARP050101064 A AR P050101064A AR P050101064 A ARP050101064 A AR P050101064A AR 048106 A1 AR048106 A1 AR 048106A1
Authority
AR
Argentina
Prior art keywords
distribution device
ray
drug distribution
device visible
contraceptive
Prior art date
Application number
ARP050101064A
Other languages
English (en)
Inventor
Harm Veenstra
Graaff Wouter De
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34928916&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR048106(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of AR048106A1 publication Critical patent/AR048106A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0404—X-ray contrast preparations containing barium sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Steroid Compounds (AREA)

Abstract

Dispositivo de distribucion de drogas visible por rayos X para administracion subdérmica de un anticonceptivo o terapia de sustitucion hormonal. Reivindicacion 1:Un dispositivo distribuidor de drogas visible por ayos X para administracion subdérmica de un anticonceptivo o terapia de sustitucion hormonal, caracterizado porque comprende un compartimiento constituido por (i) un centro polimérico termoplástico cargado con (a) una cantidad anticonceptivamente o terapéuticamente efectiva de desogestrel o 3- cetodesogestrel y (b) 6-20% en peso aproximadamente del material radio-opaco y (ii) un revestimiento polimérico termoplástico no medicado que ubre el centro.
ARP050101064A 2004-03-19 2005-03-18 Dispositivo de distribucion de drogas visible por rayos x AR048106A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04101151 2004-03-19

Publications (1)

Publication Number Publication Date
AR048106A1 true AR048106A1 (es) 2006-03-29

Family

ID=34928916

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101064A AR048106A1 (es) 2004-03-19 2005-03-18 Dispositivo de distribucion de drogas visible por rayos x

Country Status (33)

Country Link
US (1) US8722037B2 (es)
EP (1) EP1729819B1 (es)
JP (1) JP5055501B2 (es)
KR (1) KR101086619B1 (es)
CN (1) CN1953770B (es)
AR (1) AR048106A1 (es)
AT (1) ATE399569T1 (es)
AU (1) AU2005224054B2 (es)
BR (1) BRPI0508865B8 (es)
CA (1) CA2559250C (es)
CY (1) CY1108362T1 (es)
DE (1) DE602005007873D1 (es)
DK (1) DK1729819T3 (es)
EC (1) ECSP066865A (es)
EG (1) EG24359A (es)
ES (1) ES2308460T3 (es)
HK (1) HK1096316A1 (es)
HR (1) HRP20080414T3 (es)
IL (1) IL177970A (es)
LV (1) LV13521B (es)
MX (1) MXPA06010714A (es)
MY (1) MY142649A (es)
NO (1) NO338191B1 (es)
NZ (1) NZ549877A (es)
PE (1) PE20060022A1 (es)
PL (1) PL1729819T3 (es)
PT (1) PT1729819E (es)
RU (1) RU2384347C2 (es)
SI (1) SI1729819T1 (es)
TW (1) TWI434676B (es)
UA (1) UA86404C2 (es)
WO (1) WO2005089814A1 (es)
ZA (1) ZA200607602B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003267309A1 (en) 2000-11-16 2004-04-08 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
TWI434676B (zh) 2004-03-19 2014-04-21 Merck Sharp & Dohme 可用ｘ射線看出之藥物遞送裝置
KR101420988B1 (ko) 2005-10-13 2014-07-17 신세스 게엠바하 약물-함침 용기
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
WO2014204708A1 (en) 2013-06-21 2014-12-24 DePuy Synthes Products, LLC Films and methods of manufacture
US11400186B2 (en) * 2016-05-12 2022-08-02 Merck Sharp & Dohme Llc Drug delivery system for the delivery of antiviral agents
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
US10406336B2 (en) 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
WO2018064544A1 (en) * 2016-09-29 2018-04-05 Gesea Biosciences Inc. Bioerodible contraceptive implant and methods of use thereof
IL271865B1 (en) * 2017-07-08 2024-02-01 Hera Health Solutions Inc Implants for administration of drugs that degrade in the body
AU2019275409A1 (en) 2018-05-24 2020-07-16 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
SG11202005947RA (en) 2018-05-24 2020-07-29 Celanese Eva Performance Polymers Corp Implantable device for sustained release of a macromolecular drug compound

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8123912U1 (de) 1981-08-17 1982-01-14 B. Braun Melsungen Ag, 3508 Melsungen Sonde aus kunststoff
LU85320A1 (fr) 1984-04-17 1985-11-27 Oreal Composition cosmetique contenant de l'aloesine a titre d'agent de protection contre la lumiere solaire et son utilisation pour la protection de la peau et des cheveux
GB8430703D0 (en) 1984-12-05 1985-01-16 Lrc Products Drug release devices
US4866132A (en) * 1986-04-17 1989-09-12 The Research Foundation Of State University Of New York Novel radiopaque barium polymer complexes, compositions of matter and articles prepared therefrom
DE19975054I2 (de) * 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
ATE71543T1 (de) 1987-08-18 1992-02-15 Akzo Nv Injektionsvorrichtung fuer ein implantat.
JPH01178540A (ja) 1987-12-29 1989-07-14 Mitsubishi Cable Ind Ltd 医療用チューブ成形用組成物
US5141522A (en) * 1990-02-06 1992-08-25 American Cyanamid Company Composite material having absorbable and non-absorbable components for use with mammalian tissue
DE4320754A1 (de) 1993-06-23 1995-01-05 Hoechst Ag Vorrichtung zum Applizieren von Implantaten
GB9401577D0 (en) 1994-01-27 1994-03-23 Sheffield Orthodontic Lab Limi Polymer material suitable for the production of medical artifacts
US6162236A (en) * 1994-07-11 2000-12-19 Terumo Kabushiki Kaisha Trocar needle and expandable trocar tube
WO1996026682A1 (en) 1995-02-27 1996-09-06 Instent, Inc. Hollow stent
US6171326B1 (en) 1998-08-27 2001-01-09 Micrus Corporation Three dimensional, low friction vasoocclusive coil, and method of manufacture
US6174329B1 (en) 1996-08-22 2001-01-16 Advanced Cardiovascular Systems, Inc. Protective coating for a stent with intermediate radiopaque coating
IL133379A0 (en) 1997-06-20 2001-04-30 Akzo Nobel Nv Preloaded implantation device
US6174330B1 (en) 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
ES2226191T3 (es) 1997-11-07 2005-03-16 Rutgers, The State University Copolimeros de poli (oxido de aquileno) estrictamente alternantes.
US6159165A (en) 1997-12-05 2000-12-12 Micrus Corporation Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
EP0938894A1 (en) 1998-02-16 1999-09-01 Biomat B.V. Implantable radiopaque device and use thereof
US6171297B1 (en) * 1998-06-30 2001-01-09 Schneider (Usa) Inc Radiopaque catheter tip
DE29908415U1 (de) 1999-05-18 1999-07-22 Carl Mittel zur Behandlung lokaler parodontaler Infektionen
DE19946606B4 (de) * 1999-09-29 2013-07-04 Robert Bosch Gmbh Vorrichtung zum Bilden eines Kraftstoff-Luftgemischs für einen Verbrennungsmotor während einer Warmlaufphase
EP1227845A2 (de) 1999-11-09 2002-08-07 Forschungszentrum Karlsruhe GmbH Seltene erden enthaltene mischung und deren verwendung
FR2803304B1 (fr) * 1999-12-29 2006-03-24 Ceca Sa Inhibiteurs de depots inorganiques, notamment dans les puits petroliers
US6355058B1 (en) 1999-12-30 2002-03-12 Advanced Cardiovascular Systems, Inc. Stent with radiopaque coating consisting of particles in a binder
DE10004832A1 (de) * 2000-01-31 2001-08-16 Ethicon Gmbh Flächiges Implantat mit röntgensichtbaren Elementen
SE0000363L (sv) 2000-02-04 2001-08-05 Zoucas Kirurgkonsult Ab Belagd medicinsk anordning
FI20000572A (fi) 2000-03-13 2001-09-14 Leiras Oy Implantaattien asettamiseen tarkoitettu laite
DE10014518A1 (de) * 2000-03-23 2001-10-04 Aventis Pharma Gmbh Vorrichtung zum Applizieren von Implantaten
AU2002218995A1 (en) 2000-11-21 2002-06-03 Schering A.G. Tubular vascular implants (stents) and methods for producing the same
US20020138136A1 (en) 2001-03-23 2002-09-26 Scimed Life Systems, Inc. Medical device having radio-opacification and barrier layers
JP4901021B2 (ja) 2001-06-06 2012-03-21 川澄化学工業株式会社 カテーテルチューブ
US6911219B2 (en) * 2001-09-27 2005-06-28 Surgica Corporation Partially acetalized polyvinyl alcohol embolization particles, compositions containing those particles and methods of making and using them
AUPR951501A0 (en) 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
US8133501B2 (en) 2002-02-08 2012-03-13 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled drug delivery
US6887270B2 (en) * 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7214206B2 (en) 2003-04-03 2007-05-08 Valera Pharmaceuticals, Inc. Implanting device and method of using same
DE10355087A1 (de) * 2003-11-24 2005-06-09 Basf Ag Verfahren zur elektrochemischen Herstellung eines kristallinen porösen metallorganischen Gerüstmaterials
TWI434676B (zh) 2004-03-19 2014-04-21 Merck Sharp & Dohme 可用ｘ射線看出之藥物遞送裝置
CN101141994B (zh) * 2005-01-24 2010-10-13 欧加农股份有限公司 用于插入植入物的操作器
ES2685795T3 (es) 2005-01-24 2018-10-11 Merck Sharp & Dohme B.V. Aplicador para insertar un implante
USD551759S1 (en) * 2005-06-13 2007-09-25 N. V. Organon Applicator for inserting an implant
BRPI0706472B1 (pt) * 2006-01-19 2023-05-16 Merck Sharp & Dohme B.V. Kit e método para montagem de um aplicador descartável, e, aplicador descartável

Also Published As

Publication number Publication date
JP5055501B2 (ja) 2012-10-24
CA2559250C (en) 2012-07-17
KR20070027530A (ko) 2007-03-09
PT1729819E (pt) 2008-10-02
MXPA06010714A (es) 2007-03-08
RU2384347C2 (ru) 2010-03-20
IL177970A0 (en) 2006-12-31
ES2308460T3 (es) 2008-12-01
IL177970A (en) 2010-12-30
DK1729819T3 (da) 2008-10-20
HK1096316A1 (en) 2007-06-01
KR101086619B1 (ko) 2011-11-23
MY142649A (en) 2010-12-15
LV13521B (en) 2007-07-20
PL1729819T3 (pl) 2008-11-28
PE20060022A1 (es) 2006-02-11
US20080112892A1 (en) 2008-05-15
JP2007529469A (ja) 2007-10-25
HRP20080414T3 (en) 2008-09-30
SI1729819T1 (sl) 2008-12-31
ATE399569T1 (de) 2008-07-15
CN1953770B (zh) 2011-10-12
DE602005007873D1 (de) 2008-08-14
CA2559250A1 (en) 2005-09-29
TW200534838A (en) 2005-11-01
ECSP066865A (es) 2006-11-24
AU2005224054A1 (en) 2005-09-29
NO338191B1 (no) 2016-08-01
BRPI0508865A (pt) 2007-09-04
TWI434676B (zh) 2014-04-21
RU2006136913A (ru) 2008-04-27
EP1729819A1 (en) 2006-12-13
BRPI0508865B1 (pt) 2018-07-10
CY1108362T1 (el) 2014-02-12
WO2005089814A1 (en) 2005-09-29
BRPI0508865B8 (pt) 2021-05-25
CN1953770A (zh) 2007-04-25
EG24359A (en) 2009-03-04
EP1729819B1 (en) 2008-07-02
NO20064716L (no) 2006-11-28
NZ549877A (en) 2009-07-31
AU2005224054B2 (en) 2009-12-17
ZA200607602B (en) 2008-05-28
US8722037B2 (en) 2014-05-13
UA86404C2 (ru) 2009-04-27

Similar Documents

Publication Publication Date Title
AR048106A1 (es) Dispositivo de distribucion de drogas visible por rayos x
ES2641613T3 (es) Gel transdérmico de Nestorone®/Estradiol
Friend et al. Multipurpose prevention technologies: products in development
AR057060A1 (es) Composiciones de tanaproget que contienen etinil estradiol
AR031563A1 (es) Una composicion farmaceutica para emplear en el tratamiento de trastornos menopausicos o posmenopausicos de estrogenos y acetato de medroxiprogesterona, una unidad de dosificacion farmaceutica y uso de una combinacion de estrogenos conjugados y acetato de medroxiprogesterona para la manufactura de u
CO5190672A1 (es) Composicion para la dosificacion oral, de disolucion instantanea
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
HRP20070188B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
RS53876B1 (en) PARENTERAL PHARMACEUTICAL FORM, WHICH RELEASES AROMATASE AND GESTAGEN BLOCKERS, FOR THE TREATMENT OF ENDOMETRIOSIS
ES2172195T3 (es) Inhibicion de la cristalizacion en dispositivos transdermales.
PE20070188A1 (es) Formulaciones de estrogenos conjugados y bazedoxifeno
BR0214634A (pt) Sistemas terapêuticos transdérmicos contendo hormÈnio esteróide e contendo monocaprilato de propilenoglicol
WO2019113559A3 (en) Phenotypic markers for cell therapy and related methods
PE20211588A1 (es) Compuestos y sus usos para aliviar sintomas asociados a la menopausia
Burkman The transdermal contraceptive system
TW200514560A (en) Pharmaceutical formulation for contraception and hormone-replacement therapy
AR049197A1 (es) Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona
CL2007001961A1 (es) Composicion farmaceutica que contiene a) 2,0 mg de dienogest y 0,015 mg de etinilestradiol y (6s)-5-metil-tetrahidrofolato y uno o mas excipiente/vehiculos; kit; uso para la anticoncepcion femeneina y reducir el riesgo d malformaciones congenitas debidas a la falta de folato en el embarazo.
CA2478165A1 (en) Sulfatase inhibiting progestogen-only contraceptive regimens
BR0214159A (pt) Sistema farmacêutico radiopaco de liberação prolongada
PE20031047A1 (es) Tratamiento de padecimientos post-menopausicos en pacientes con cancer de mama
CO5601036A2 (es) Composicion farmaceutica de liberacion sostenida
CO5590926A2 (es) Uso de anastrozol para el tratamiento de mujeres posmenopausicas que tienen cancer precoz de mama
PE20060402A1 (es) Combinacion farmaceutica de etinilestradiol y acetato de clormadinona
AR070375A1 (es) Sistemas de administracion de drogas que contienen estradiol

Legal Events

Date Code Title Description
FC Refusal